Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-08-03 4:59 pm Unchanged |
2023-08-01 | 13D | Xtant Medical Holdings, Inc. XTNT |
ORBIMED ADVISORS LLC | 73,114,592 56.700% |
0 (Unchanged) |
Filing History |
| 2023-08-02 5:02 pm Sale |
2023-07-31 | 13D | Galecto, Inc. GLTO |
ORBIMED ADVISORS LLC | 89,658 8.300% |
-8,568 (-8.72%) |
Filing History |
| 2023-07-24 4:33 pm Purchase |
2023-07-20 | 13D | Turnstone Biologics Corp. TSBX |
ORBIMED ADVISORS LLC | 3,099,265 13.400% |
3,099,265 (New Position) |
Filing History |
| 2023-07-19 4:12 pm Purchase |
2023-07-17 | 13D | Theseus Pharmaceuticals, Inc. THRX |
ORBIMED ADVISORS LLC | 17,713,600 40.700% |
479,932 (+2.78%) |
Filing History |
| 2023-07-17 4:11 pm Sale |
2023-07-13 | 13D | Galecto, Inc. GLTO |
ORBIMED ADVISORS LLC | 98,226 9.600% |
-9,641 (-8.94%) |
Filing History |
| 2023-06-29 4:36 pm Purchase |
2023-06-27 | 13D | Passage Bio, Inc. PASG |
ORBIMED ADVISORS LLC | 8,034,000 14.700% |
1,192,577 (+17.43%) |
Filing History |
| 2023-06-29 4:30 pm Purchase |
2023-06-27 | 13D | Adicet Bio, Inc. ACET |
ORBIMED ADVISORS LLC | 6,647,598 15.500% |
6,647,598 (New Position) |
Filing History |
| 2023-06-21 4:53 pm Purchase |
2023-06-16 | 13D | Disc Medicine, Inc. IRON |
ORBIMED ADVISORS LLC | 2,269,637 10.200% |
108,696 (+5.03%) |
Filing History |
| 2023-05-24 4:52 pm Sale |
2023-05-21 | 13D | VectivBio Holding AG VECT |
ORBIMED ADVISORS LLC | 5,156,561 7.700% |
-1,557,000 (-23.19%) |
Filing History |
| 2023-05-24 4:47 pm Purchase |
2023-05-22 | 13D | Prelude Therapeutics Incorporated PRLD |
ORBIMED ADVISORS LLC | 15,716,642 28.600% |
869,565 (+5.86%) |
Filing History |
| 2023-05-17 4:46 pm Sale |
2023-05-15 | 13D | SpringWorks Therapeutics, Inc. SWTX |
ORBIMED ADVISORS LLC | 4,178,588 6.700% |
-806,412 (-16.18%) |
Filing History |
| 2023-05-16 4:28 pm Unchanged |
2023-05-11 | 13D | Fusion Pharmaceuticals Inc. FUSN |
ORBIMED ADVISORS LLC | 2,930,670 4.600% |
0 (Unchanged) |
Filing History |
| 2023-05-16 4:25 pm Sale |
2023-05-15 | 13D | 89bio, Inc. ETNB |
ORBIMED ADVISORS LLC | 3,777,778 4.800% |
-482,913 (-11.33%) |
Filing History |
| 2023-05-08 5:01 pm Purchase |
2023-05-04 | 13D | Kinnate Biopharma Inc. KNTE |
ORBIMED ADVISORS LLC | 7,559,729 16.200% |
1,460,932 (+23.95%) |
Filing History |
| 2023-05-05 11:14 am Unchanged |
2023-05-01 | 13D | Xtant Medical Holdings, Inc. XTNT |
ORBIMED ADVISORS LLC | 73,114,592 67.100% |
0 (Unchanged) |
Filing History |
| 2023-05-02 7:28 pm Purchase |
2023-04-28 | 13D | Kinnate Biopharma Inc. KNTE |
ORBIMED ADVISORS LLC | 6,098,797 13.100% |
1,405,168 (+29.94%) |
Filing History |
| 2023-04-21 5:03 pm Sale |
2023-04-19 | 13D | TELA Bio, Inc. TELA |
ORBIMED ADVISORS LLC | 2,866,267 11.900% |
-192,000 (-6.28%) |
Filing History |
| 2023-04-11 7:10 pm Purchase |
2023-03-29 | 13D | Apollomics, Inc. APLM |
ORBIMED ADVISORS LLC | 6,626 10.300% |
6,626 (New Position) |
Filing History |
| 2023-04-07 4:38 pm Sale |
2023-04-05 | 13D | Galecto, Inc. GLTO |
ORBIMED ADVISORS LLC | 107,866 10.500% |
-2,992 (-2.70%) |
Filing History |
| 2023-03-31 4:48 pm Purchase |
2023-03-29 | 13D | Gracell Biotechnologies Inc. GRCL |
ORBIMED ADVISORS LLC | 7,583,576 11.200% |
1,612,904 (+27.01%) |
Filing History |